(Q34981345)

5 August 2017

1 reference

title

CDKs and CKIs: molecular targets for tissue remodelling (English)

1 reference

5 August 2017

Elizabeth G Nabel

1

1 reference

5 August 2017

publication date

1 August 2002

1 reference

Nature Reviews Drug Discovery

5 August 2017

number of pages

12

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

5 August 2017

volume

1

1 reference

5 August 2017

issue

8

1 reference

5 August 2017

page(s)

587-598

1 reference

Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit.

5 August 2017

cites work

1 reference

The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases

31 March 2020

1 reference

WAF1, a potential mediator of p53 tumor suppression

31 March 2020

1 reference

p21 is a universal inhibitor of cyclin kinases

31 March 2020

1 reference

p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest.

31 March 2020

1 reference

p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest

31 March 2020

1 reference

Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals

31 March 2020

1 reference

p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21

31 March 2020

1 reference

Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution

31 March 2020

1 reference

p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene

31 March 2020

1 reference

Separate domains of p21 involved in the inhibition of Cdk kinase and PCNA.

31 March 2020

1 reference

Cyclin-binding motifs are essential for the function of p21CIP1

31 March 2020

1 reference

A small peptide inhibitor of DNA replication defines the site of interaction between the cyclin-dependent kinase inhibitor p21WAF1 and proliferating cell nuclear antigen

31 March 2020

1 reference

Analysis of wild-type and mutant p21WAF-1 gene activities

31 March 2020

1 reference

Crystal structure of the p27Kip1 cyclin-dependent-kinase inhibitor bound to the cyclin A-Cdk2 complex

31 March 2020

1 reference

A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4

31 March 2020

1 reference

p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest

31 March 2020

1 reference

Growth suppression by p18, a p16INK4/MTS1- and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function

31 March 2020

1 reference

Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6

31 March 2020

1 reference

Identification of human and mouse p19, a novel CDK4 and CDK6 inhibitor with homology to p16ink4

31 March 2020

1 reference

31 March 2020

1 reference

CDK inhibitors: positive and negative regulators of G1-phase progression

31 March 2020

1 reference

Subunit rearrangement of the cyclin-dependent kinases is associated with cellular transformation

31 March 2020

1 reference

Expression of cyclin-dependent kinase inhibitors in vascular disease

31 March 2020

1 reference

Cyclin E-CDK2 is a regulator of p27Kip1.

31 March 2020

1 reference

p27 cytoplasmic localization is regulated by phosphorylation on Ser10 and is not a prerequisite for its proteolysis

31 March 2020

1 reference

Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27

31 March 2020

1 reference

Negative regulation of G1 in mammalian cells: inhibition of cyclin E-dependent kinase by TGF-beta.

31 March 2020

1 reference

Molecular characterization of the cyclin-dependent kinase inhibitor p27 promoter

31 March 2020

1 reference

Phosphorylation at serine 10, a major phosphorylation site of p27(Kip1), increases its protein stability

31 March 2020

1 reference

Differential regulation of p27(Kip1) expression by mitogenic and hypertrophic factors: Involvement of transcriptional and posttranscriptional mechanisms

31 March 2020

1 reference

Repression of p27kip1 synthesis by platelet-derived growth factor in BALB/c 3T3 cells

31 March 2020

1 reference

Enhanced ribosomal association of p27(Kip1) mRNA is a mechanism contributing to accumulation during growth arrest.

31 March 2020

1 reference

Control of cyclin-dependent kinase inhibitor p27 expression by cap-independent translation

31 March 2020

1 reference

A mouse knock-in model exposes sequential proteolytic pathways that regulate p27Kip1 in G1 and S phase

31 March 2020

1 reference

A growth factor-dependent nuclear kinase phosphorylates p27(Kip1) and regulates cell cycle progression

31 March 2020

1 reference

Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27

31 March 2020

1 reference

A complex of Cdc4p, Skp1p, and Cdc53p/cullin catalyzes ubiquitination of the phosphorylated CDK inhibitor Sic1p

31 March 2020

1 reference

SKP1 connects cell cycle regulators to the ubiquitin proteolysis machinery through a novel motif, the F-box

31 March 2020

1 reference

F-box proteins are receptors that recruit phosphorylated substrates to the SCF ubiquitin-ligase complex

31 March 2020

1 reference

p45SKP2 promotes p27Kip1 degradation and induces S phase in quiescent cells

31 March 2020

1 reference

SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27

31 March 2020

1 reference

p27(Kip1) ubiquitination and degradation is regulated by the SCF(Skp2) complex through phosphorylated Thr187 in p27

31 March 2020

1 reference

Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors

31 March 2020

1 reference

Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1).

31 March 2020

1 reference

A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice

31 March 2020

1 reference

Radiation-induced cell cycle arrest compromised by p21 deficiency

31 March 2020

1 reference

Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control

31 March 2020

1 reference

The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA

31 March 2020

1 reference

Cell-cycle inhibition by independent CDK and PCNA binding domains in p21Cip1

31 March 2020

1 reference

Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD.

31 March 2020

1 reference

p53-independent expression of p21Cip1 in muscle and other terminally differentiating cells

31 March 2020

1 reference

Inactivation of a Cdk2 inhibitor during interleukin 2-induced proliferation of human T lymphocytes

31 March 2020

1 reference

Interleukin-2-mediated elimination of the p27Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin

31 March 2020

1 reference

Requirement of p27Kip1 for restriction point control of the fibroblast cell cycle

31 March 2020

1 reference

Cyclic AMP-induced G1 phase arrest mediated by an inhibitor (p27Kip1) of cyclin-dependent kinase 4 activation.

31 March 2020

1 reference

Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta

31 March 2020

1 reference

Cell proliferation in human coronary arteries

31 March 2020

1 reference

Fibrillar collagen inhibits arterial smooth muscle proliferation through regulation of Cdk2 inhibitors

31 March 2020

1 reference

Differential effects of the cyclin-dependent kinase inhibitors p27(Kip1), p21(Cip1), and p16(Ink4) on vascular smooth muscle cell proliferation.

31 March 2020

1 reference

Role of the p21 cyclin-dependent kinase inhibitor in limiting intimal cell proliferation in response to arterial injury

31 March 2020

1 reference

Adenovirus-mediated over-expression of the cyclin/cyclin-dependent kinase inhibitor, p21 inhibits vascular smooth muscle cell proliferation and neointima formation in the rat carotid artery model of balloon angioplasty

31 March 2020

1 reference

ACC/AHA guidelines for percutaneous coronary intervention (revision of the 1993 PTCA guidelines)—executive summary21When citing this document, the American College of Cardiology and the American Heart Association would appreciate the following cita

31 March 2020

1 reference

Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty

31 March 2020

1 reference

Rapamycin (AY-22,989), a new antifungal antibiotic. I. Taxonomy of the producing streptomycete and isolation of the active principle

31 March 2020

1 reference

Rapamycin (AY-22,989), a new antifungal antibiotic. II. Fermentation, isolation and characterization.

31 March 2020

1 reference

Cellular functions of immunophilins

31 March 2020

1 reference

Rapamycin-FKBP inhibits cell cycle regulators of proliferation in vascular smooth muscle cells

31 March 2020

1 reference

Rapamycin inhibits vascular smooth muscle cell migration

31 March 2020

1 reference

Two distinct signal transmission pathways in T lymphocytes are inhibited by complexes formed between an immunophilin and either FK506 or rapamycin

31 March 2020

1 reference

Inhibition of intimal thickening after balloon angioplasty in porcine coronary arteries by targeting regulators of the cell cycle

31 March 2020

1 reference

Rapamycin resistance tied to defective regulation of p27Kip1.

31 March 2020

1 reference

Role for p27(Kip1) in Vascular Smooth Muscle Cell Migration

31 March 2020

1 reference

Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries: a quantitative coronary angiography and three-dimensional intravascular ultrasound study

31 March 2020

1 reference

Sustained suppression of neointimal proliferation by sirolimus-eluting stents: one-year angiographic and intravascular ultrasound follow-up

31 March 2020

1 reference

A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization

31 March 2020

1 reference

Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia

31 March 2020

1 reference

Taxol stabilizes microtubules in mouse fibroblast cells

31 March 2020

1 reference

31 March 2020

1 reference

Taxol inhibits neointimal smooth muscle cell accumulation after angioplasty in the rat

31 March 2020

1 reference

Paclitaxel stent coating inhibits neointimal hyperplasia at 4 weeks in a porcine model of coronary restenosis

31 March 2020

1 reference

Reduction in levels of the cyclin-dependent kinase inhibitor p27(kip-1) coupled with transforming growth factor beta neutralization induces cell-cycle entry and increases retroviral transduction of primitive human hematopoietic cells

31 March 2020

1 reference

A positive effect of p21cip1/waf1 in the colony formation from murine myeloid progenitor cells as assessed by retroviral-mediated gene transfer

31 March 2020

1 reference

Hematopoietic stem cell quiescence maintained by p21cip1/waf1

31 March 2020

1 reference

Stem cell repopulation efficiency but not pool size is governed by p27(kip1).

31 March 2020

1 reference

The cyclin-dependent kinase inhibitor p27Kip1 safeguards against inflammatory injury

31 March 2020

1 reference

31 March 2020

1 reference

p27kip1 functions as an anergy factor inhibiting interleukin 2 transcription and clonal expansion of alloreactive human and mouse helper T lymphocytes

31 March 2020

1 reference

Fibroblast growth factor inhibits chondrocytic growth through induction of p21 and subsequent inactivation of cyclin E-Cdk2

31 March 2020

1 reference

Involvement of the cell-cycle inhibitor Cip1/WAF1 and the E1A-associated p300 protein in terminal differentiation.

31 March 2020

1 reference

The absence of p21Cip1/WAF1 alters keratinocyte growth and differentiation and promotes ras-tumor progression.

31 March 2020

1 reference

p21 (WAF1/CIP1) expression is induced in newly nondividing cells in diverse epithelia and during differentiation of the Caco-2 intestinal cell line.

31 March 2020

1 reference

The cyclin kinase inhibitor p21WAF1/CIP1 is required for glomerular hypertrophy in experimental diabetic nephropathy

31 March 2020

1 reference

Resistance to apoptosis conferred by Cdk inhibitors during myocyte differentiation.

31 March 2020

1 reference

p21(WAF1/Cip1) functions as a suppressor of malignant skin tumor formation and a determinant of keratinocyte stem-cell potential

31 March 2020

1 reference

31 March 2020

1 reference

The prognostic significance of altered cyclin-dependent kinase inhibitors in human cancer

31 March 2020

1 reference

p53, the cellular gatekeeper for growth and division

31 March 2020

1 reference

The complexity of p53 modulation: emerging patterns from divergent signals

31 March 2020

1 reference

The retinoblastoma protein and cell cycle control

31 March 2020

1 reference

The INK4a/ARF network in tumour suppression

31 March 2020

1 reference

The cellular response to p53: the decision between life and death

31 March 2020

1 reference

Mechanisms of p53-mediated apoptosis

31 March 2020

1 reference

Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest

31 March 2020

1 reference

31 March 2020

Gene therapy of cancer

1 reference

Selective killing of transformed cells by cyclin/cyclin-dependent kinase 2 antagonists

31 March 2020

1 reference

Inhibitors of cyclin-dependent kinases as anti-cancer therapeutics

31 March 2020

1 reference

Phase I trial of continuous infusion flavopiridol, a novel cyclin-dependent kinase inhibitor, in patients with refractory neoplasms.

31 March 2020

1 reference

Small molecule modulators of cyclin-dependent kinases for cancer therapy

31 March 2020

1 reference

Cell-cycle arrest and inhibition of Cdk4 activity by small peptides based on the carboxy-terminal domain of p21WAF1

31 March 2020

1 reference

Identification of E2F-1/Cyclin A antagonists.

31 March 2020

1 reference

An artificial cell-cycle inhibitor isolated from a combinatorial library

31 March 2020

1 reference

Combinatorial protein reagents to manipulate protein function.

31 March 2020

1 reference

Cyclin E in human cancers.

31 March 2020

1 reference

Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas.

31 March 2020

1 reference

Decreased levels of the cell-cycle inhibitor p27Kip1 protein: prognostic implications in primary breast cancer

31 March 2020

1 reference

Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients

31 March 2020

1 reference

Role of cyclin-dependent kinase inhibitors in the growth arrest at senescence in human prostate epithelial and uroepithelial cells

31 March 2020

1 reference

The murine gene p27Kip1 is haplo-insufficient for tumour suppression

31 March 2020

1 reference

Prevention of chemotherapy-induced alopecia in rats by CDK inhibitors

31 March 2020

1 reference

Cell cycle and cell migration: new pieces to the puzzle

31 March 2020

1 reference

Inhibitory function of p21Cip1/WAF1 in differentiation of primary mouse keratinocytes independent of cell cycle control

31 March 2020

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/NRD869

1 reference

5 August 2017

1 reference